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Abstract  
Primary bone lymphoma (PBL) is a relatively uncommon entity. However, involvement of the cranial vault is an unusual manifestation of aggressive 
non-Hodgkin’s lymphoma. We report the case of a 42-year old immunocompetent woman who presented with an enlarging mass involving the 
right parietal bone. Magnetic resonance imaging (MRI) of the brain revealed an expansive tumor that affects the right parietal bone. Computed 
tomographic (CT) scans of the abdomen, chest and pelvis were negative for lymphadenopathy or organomegaly. Biopsy of the mass showed 
diffuse large B-cell non-Hodgkin’s lymphoma confirmed by immunohistochemical study. The patient had a complete response after 4 cycles of 
chemotherapy followed by external beam radiotherapy. After a follow-up of more than 9 months the patient is still in good local control without 
distant metastasis. The aim of our work is to report a case of Primary bone lymphoma of the cranial vault with good response to treatment 
combining sequential chemotherapy and radiotherapy.  
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Background 
 
Primary bone lymphoma (PBL) represents about 5% of all non-Hodgkin lymphomas (NHL) and 3% of all bone malignancies [1]. The femur, tibia 
and  pelvis  are  the  most  common  skeletal  sites  [1].  To  our  knowledge,  only  fourteen  immunocompetent  patients  with  primary  cranial  vault 
lymphoma  have  been  reported  in  the  literature  [2-15].  Because  of  the  rarity  of  this  entity  and  the  lack  of  evident  literature,  its  optimal 
management is still unknown. We report a case of good response to treatment combining sequential chemotherapy and radiotherapy. We report a 
case of primary bone lymphoma of the cranial vault with good response to treatment combining sequential chemotherapy and radiotherapy.  
  
  
Case presentation 
 
A 42-year old immunocompetent woman presented with a 10-month history of enlarging mass involving the right parietal bone without history of 
trauma. Physical examination showed a localized mass of 8 x 6 cm in diameter, in the right parietal region. There was no erythema and it was firm 
and slightly tender. The remainder of the examination was unremarkable; in particular no lymphadenopathy and no abdominal masses were felt.  
  
Neurological examination was normal. MRI of the brain revealed an expansive tumor (11 x 5 cm) affecting the right parietal bone, including the 
scalp  (Figure  1).  There  was  no  evidence  of  parenchymal  involvement.  CT  scans  of  the  abdomen;  chest  and  pelvis  were  negative  for 
lymphadenopathy or organomegaly. There was no evidence of bone marrow involvement.  
  
Biopsy of the mass with histopathology analysis showed diffuse architecture with mixture of large cleaved (centroblastic/centrocytic) and large 
noncleaved (centroblastic monomorphous) cells. The cytoplasm was scanty. The tumor cells did stain for CD20, CD79a and bcl2 protein. The 
proliferating  fraction,  as  detected  by  Ki67  was  high  (more  than  80%  of  neoplastic  cells).  The  CD3  T-cell  marker  was  negative.  The 
immunohistochemical tests confirmed the diagnosis of large B-cell lymphoma (Figure 2). Based upon her clinical and histological presentation and 
radiographic images, the diagnosis of stage IE primary lymphoma of the cranial vault, according to the Ann Arbor classification system, was 
established. The patient received 4 cycles of rituximab 375 mg/m2 iv day 1 (d1), cyclophosphamide 750 mg/m2 iv d1, doxorubicin 50 mg/m2 iv 
d1, vincristine 1.4 mg/m2 iv d1, and prednisone 100 mg d1-5 combination chemotherapy (RCHOP) every 3 weeks, followed by involved field 
radiation. The patient had a remarkable improvement with a complete response after treatment and optimal local control after 9 months of follow-
up.  
  
  
Discussion 
 
The diagnosis of PBL is more definite in patients who present with isolated bone localisations of lymphoma without other sites of involvement. Most 
series show a male preponderance, higher likelihood of early-stage disease presentation, and a median age of presentation in the fifth or sixth 
decade. Involvement of the cranial vault is an unusual manifestation of non-Hodgkin’s lymphoma in patients without HIV infection. Only fourteen 
patients with non-HIV related primary cranial vault lymphoma have been reported in the literature [2-15]. Our patient was HIV negative and 
presented young age in comparison to the literature. Symptoms of lymphoma in the skull include a painless scalp lump, headache and focal 
neurological  deficits  [2,9,11,12].  In  our  case  painless  subcutaneous  scalp  lump  was  not  associated  with  any  neurological  deficits.  MRI  of 
lymphomas cannot be specific because its appearance can mimic those of metastatic carcinoma, osteomyelitis, or meningioma, although the signal 
intensity of a lymphoma on MRI is non-specific, most reported cases of skull lymphomas were isointense on unenhanced MRI and showed marked 
enhancement after administration of contrast medium [13]. Because of the characteristic permeating growth pattern of lymphoma with large soft 
tissue component, bone destruction may not be seen as in present case. Besides, to confirm a diagnosis of cranial vault lymphoma, an IHC analysis 
is necessary. Most lymphomas of the cranial vault are B-cell non Hodgkin lymphoma [2-15], as in our case. In the literature review of 14 patients, 
complete remission was achieved in 75 % patients with median remission duration of 7 months (range, 1-72). Three of these patients were still 
disease free after 2 years. 60% received whole brain radiation alone, 40% received systemic chemotherapy plus whole brain radiation, and one 
received  whole  brain  radiation  and  intrathecal  methotrexate.  However,  combined  modality  treatment  including  anthracycline-based  systemic 
chemotherapy and involved field radiation therapy is considered the standard for localized aggressive non-Hodgkin’s lymphoma [1]. Our case 
showed a good clinical outcome with complete response after a combination of sequential chemotherapy and radiotherapy.  
  
Despite the increasing number of primary bone lymphoma and recent therapeutic advances, several questions still remain unanswered about the 
optimal management of these tumors. We believe that four cycles of a chemotherapeutic regimen (RCHOP) followed by involved field radiotherapy 
is the appropriate regimen for patients with primary localized cranial vault lymphoma. Furthermore, exclusive irradiation should be proposed for 
isolated cases. The prognosis is uncertain, but either direct cerebral invasion or leptomeningeal seeding should indicate a less favorable prognosis 
[13].  
  
  
Conclusion 
 
This case demonstrates that PBL must be kept in mind in the differential diagnosis of primary lesions in the skull. Chemotherapy followed by 
involved field irradiation, appears to be an adapted therapy.  
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Figures 
 
Figure 1: Sagittal T1 flair showing an expansive tumor that affects the right parietal bone in a 42-years old patient with primary non Hodgkin’s 
lymphoma of the cranial vault. 
 
Figure 2: Diffuse large B cell lymphoma positive for CD20 (immunohistochemistry CD20 original magnification x400).  
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